SUSTAINED VIRAL RESPONSE AND SAFETY OF MK-7009 IN CIRRHOTIC TREATMENT-EXPERIENCED PATIENTS WITH GENOTYPE 1 HCV INFECTION WHO HAVE FAILED PREVIOUS PEGYLATED INTERFERON AND RIBAVIRIN TREATMENT

被引：1
|
作者：
Rodriguez-Torres, M. [1 ]
Stoehr, A. [2 ]
Gane, E. [3 ]
Serfaty, L. [4 ]
Lawitz, E. [5 ]
Bourque, M. [6 ,7 ]
Bhanja, S. [6 ,7 ]
Barnard, R. [6 ,7 ]
Hwang, P. [6 ,7 ]
Mobashery, N. [6 ,7 ]
机构：
[1] Fdn Invest Diego, San Juan, PR USA
[2] IFI Inst Interdisziplinare Med, Hamburg, Germany
[3] Auckland Clin Studies Ltd, Auckland, New Zealand
[4] Univ Paris 06, Serv Hepatol, Paris, France
[5] Alamo Med Res, San Antonio, TX USA
[6] Merck Sharp & Dohme Corp, West Point, PA USA
[7] Merck Sharp & Dohme Corp, N Wales, PA USA
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60108-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
106
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [1] RESISTANCE ANALYSIS OF CIRRHOTIC TREATMENT-EXPERIENCED GENOTYPE 1 PATIENTS IN A STUDY OF MK-7009 IN COMBINATION WITH PEGYLATED INTERFERON/RIBAVIRIN
    Barnard, R.
    Hwang, P. M. T.
    Bhanja, S.
    Campbell, H.
    Strizki, J.
    Cheney, C.
    McHale, C.
    Newhard, W.
    Hazuda, D.
    Mobashery, N.
    Howe, A.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S487 - S487
  • [2] A PHASE 2B STUDY OF MK-7009 (VANIPREVIR) IN PATIENTS WITH GENOTYPE 1 HCV INFECTION WHO HAVE FAILED PREVIOUS PEGYLATED INTERFERON AND RIBAVIRIN TREATMENT
    Lawitz, Eric
    Rodriguez-Torres, Maribel
    Stoehr, Albrecht
    Gane, Edward J.
    Serfaty, Lawrence
    Bhanja, Sanhita
    Barnard, Richard J.
    An, Di
    Gress, Jacqueline
    Hwang, Peggy
    Mobashery, Niloufar
    HEPATOLOGY, 2011, 54 : 1434A - 1435A
  • [3] A phase 2B study of MK-7009 (vaniprevir) in patients with genotype 1 HCV infection who have failed previous pegylated interferon and ribavirin treatment
    Lawitz, Eric
    Rodriguez-Torres, Maribel
    Stoehr, Albrecht
    Gane, Edward J.
    Serfaty, Lawrence
    Bhanja, Sanhita
    Barnard, Richard J.
    An, Di
    Gress, Jacqueline
    Hwang, Peggy
    Mobashery, Niloufar
    JOURNAL OF HEPATOLOGY, 2013, 59 (01) : 11 - 17
  • [4] COMPARATIVE RESISTANCE ANALYSIS BETWEEN CIRRHOTIC AND NON-CIRRHOTIC TREATMENT EXPERIENCED PATIENTS WHO FAILED TREATMENT WITH A COMBINATION OF VANIPREVIR (MK-7009) AND PEGYLATED INTERFERON AND RIBAVIRIN (P/R)
    Ludmerer, S.
    Barnard, R.
    Brunhoffer, J.
    Howe, A.
    Hwang, P. M. T.
    Liu, R.
    Zhou, A.
    Mobashery, N.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S497 - S498
  • [5] Vaniprevir (MK-7009) Demonstrates Higher Exposures in Treatment-Experienced Genotype (GT) 1 Cirrhotic Than Non-cirrhotic HCV-Infected Patients
    Gao, Wei
    Caro, Luzelena
    Anderson, Melanie
    Hwang, Peggy
    Zhou, Amy
    Su, Jing
    Mobashery, Niloufar
    HEPATOLOGY, 2013, 58 : 739A - 739A
  • [6] Pegylated interferon and Ribavirin for the treatment of HCV infected patients who failed previous interferon therapy
    Gaglio, PJ
    Regenstein, FG
    Vlacos, MN
    Bartholomew, D
    Randazzo, P
    GASTROENTEROLOGY, 2001, 120 (05) : A384 - A384
  • [7] Pegylated interferon and ribavirin for the treatment of HCV infected patients who failed previous therapy.
    Gaglio, PJ
    Regenstein, F
    Bartholomew, D
    Vlacos, M
    HEPATOLOGY, 2001, 34 (04) : 577A - 577A
  • [8] THE ASPIRE TRIAL: TMC435 IN TREATMENT-EXPERIENCED PATIENTS WITH GENOTYPE-1 HCV INFECTION WHO HAVE FAILED PREVIOUS PEGIFN/RBV TREATMENT
    Zeuzem, S.
    Foster, G. R.
    Fried, M. W.
    Hezode, C.
    Hirschfield, G. M.
    Nikitin, I.
    Poordad, F.
    Lenz, O.
    Peeters, M.
    Sekar, V.
    De Smedt, G.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S546 - S546
  • [9] TMC435 IN PATIENTS INFECTED WITH HCV GENOTYPE 1 WHO HAVE FAILED PREVIOUS PEGYLATED INTERFERON/RIBAVIRIN TREATMENT: VIROLOGIC ANALYSES OF THE ASPIRE TRIAL
    Lenz, O.
    Fevery, B.
    Vijgen, L.
    Verbeeck, J.
    Peeters, M.
    Beumont-Mauviel, M.
    Zeuzem, S.
    Picchio, G.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S5 - S5
  • [10] TMC435 in Patients Infected with HCV Genotype 1 Who Have Failed Previous Pegylated Interferon/Ribavirin Treatment: Virologic Analyses of The ASPIRE Trial
    Picchio, Gaston
    Lenz, Oliver
    Fevery, Bart
    Vijgen, Leen
    Verbeeck, Jannick
    Peeters, Monika
    Beumont-Mauviel, Maria
    Zeuzem, Stefan
    GASTROENTEROLOGY, 2012, 142 (05) : S145 - S145
12345